ロード中...
(18)F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma
Liver transplantation (LT) has become standard of care in patients with non-resectable early stage hepatocellular carcinoma (HCC) in liver cirrhosis. Currently, patient selection for LT is strictly based on tumor size and number, provided by the Milan criteria. This may, however, exclude patients wi...
保存先:
| 出版年: | J Clin Transl Hepatol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
XIA & HE Publishing Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5606969/ https://ncbi.nlm.nih.gov/pubmed/28936404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2017.00014 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|